» Articles » PMID: 21177493

The Mammalian MAPK/ERK Pathway Exhibits Properties of a Negative Feedback Amplifier

Overview
Journal Sci Signal
Date 2010 Dec 24
PMID 21177493
Citations 126
Authors
Affiliations
Soon will be listed here.
Abstract

Three-tiered kinase modules, such as the Raf-MEK (mitogen-activated or extracellular signal-regulated protein kinase kinase)-ERK (extracellular signal-regulated kinase) mitogen-activated protein kinase pathway, are widespread in biology, suggesting that this structure conveys evolutionarily advantageous properties. We show that the three-tiered kinase amplifier module combined with negative feedback recapitulates the design principles of a negative feedback amplifier (NFA), which is used in electronic circuits to confer robustness, output stabilization, and linearization of nonlinear signal amplification. We used mathematical modeling and experimental validation to demonstrate that the ERK pathway has properties of an NFA that (i) converts intrinsic switch-like activation kinetics into graded linear responses, (ii) conveys robustness to changes in rates of reactions within the NFA module, and (iii) stabilizes outputs in response to drug-induced perturbations of the amplifier. These properties determine biological behavior, including activation kinetics and the response to drugs.

Citing Articles

Mathematical Modeling and Inference of Epidermal Growth Factor-Induced Mitogen-Activated Protein Kinase Cell Signaling Pathways.

Feng J, Zhang X, Tian T Int J Mol Sci. 2024; 25(18).

PMID: 39337687 PMC: 11432143. DOI: 10.3390/ijms251810204.


Interference with Systemic Negative Feedback Regulation as a Potential Mechanism for Nonmonotonic Dose-Responses of Endocrine-Disrupting Chemicals.

Shi Z, Xiao S, Zhang Q bioRxiv. 2024; .

PMID: 39282254 PMC: 11398479. DOI: 10.1101/2024.09.04.611257.


Cell State Transition Models Stratify Breast Cancer Cell Phenotypes and Reveal New Therapeutic Targets.

Rukhlenko O, Imoto H, Tambde A, McGillycuddy A, Junk P, Tuliakova A Cancers (Basel). 2024; 16(13).

PMID: 39001416 PMC: 11240448. DOI: 10.3390/cancers16132354.


Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies.

Bahar M, Kim H, Kim D Signal Transduct Target Ther. 2023; 8(1):455.

PMID: 38105263 PMC: 10725898. DOI: 10.1038/s41392-023-01705-z.


A guide to ERK dynamics, part 1: mechanisms and models.

Ram A, Murphy D, DeCuzzi N, Patankar M, Hu J, Pargett M Biochem J. 2023; 480(23):1887-1907.

PMID: 38038974 PMC: 10754288. DOI: 10.1042/BCJ20230276.